Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Payment Methods
  9. Questions
  10. Schema
  11. External Links
  12. Analytics And Tracking
  13. Libraries
  14. CDN Services

We are analyzing https://link.springer.com/article/10.1186/s12929-020-00633-2.

Title:
Clinical-grade cryopreserved doxorubicin-loaded platelets: role of cancer cells and platelet extracellular vesicles activation loop | Journal of Biomedical Science
Description:
Background Human platelets (PLT) and PLT-extracellular vesicles (PEV) released upon thrombin activation express receptors that interact with tumour cells and, thus, can serve as a delivery platform of anti-cancer agents. Drug-loaded nanoparticles coated with PLT membranes were demonstrated to have improved targeting efficiency to tumours, but remain impractical for clinical translation. PLT and PEV targeted drug delivery vehicles should facilitate clinical developments if clinical-grade procedures can be developed. Methods PLT from therapeutic-grade PLT concentrate (PC; N > 50) were loaded with doxorubicin (DOX) and stored at − 80 °C (DOX-loaded PLT) with 6% dimethyl sulfoxide (cryopreserved DOX-loaded PLT). Surface markers and function of cryopreserved DOX-loaded PLT was confirmed by Western blot and thromboelastography, respectively. The morphology of fresh and cryopreserved naïve and DOX-loaded PLT was observed by scanning electron microscopy. The content of tissue factor-expressing cancer-derived extracellular vesicles (TF-EV) present in conditioned medium (CM) of breast cancer cells cultures was measured. The drug release by fresh and cryopreserved DOX-loaded PLT triggered by various pH and CM was determined by high performance liquid chromatography. The thrombin activated PEV was analyzed by nanoparticle tracking analysis. The cellular uptake of DOX from PLT was observed by deconvolution microscopy. The cytotoxicities of DOX-loaded PLT, cryopreserved DOX-loaded PLT, DOX and liposomal DOX on breast, lung and colon cancer cells were analyzed by CCK-8 assay. Results 15~36 × 106 molecules of DOX could be loaded in each PLT within 3 to 9 days after collection. The characterization and bioreactivity of cryopreserved DOX-loaded PLT were preserved, as evidenced by (a) microscopic observations, (b) preservation of important PLT membrane markers CD41, CD61, protease activated receptor-1, (c) functional activity, (d) reactivity to TF-EV, and (e) efficient generation of PEV upon thrombin activation. The transfer of DOX from cryopreserved PLT to cancer cells was achieved within 90 min, and stimulated by TF-EV and low pH. The cryopreserved DOX-loaded PLT formulation was 7~23-times more toxic to three cancer cells than liposomal DOX. Conclusions Cryopreserved DOX-loaded PLT can be prepared under clinically compliant conditions preserving the membrane functionality for anti-cancer therapy. These findings open perspectives for translational applications of PLT-based drug delivery systems.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Science
  • Education
  • Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

The income method remains a mystery to us.

Some websites aren't about earning revenue; they're built to connect communities or raise awareness. There are numerous motivations behind creating websites. This might be one of them. Link.springer.com might be making money, but it's not detectable how they're doing it.

Keywords {🔍}

plt, dox, doxloaded, cancer, pubmed, cells, article, google, scholar, cryopreserved, cas, release, cell, pev, drug, platelet, fig, blood, min, tumour, activation, delivery, platelets, thrombin, pas, loaded, medium, membrane, mdamb, central, plasma, taipei, fresh, assay, liposomal, generation, tfev, capacity, solution, incubated, loading, breast, vitro, usa, doxorubicin, microscopy, activity, microenvironment, medical, control,

Topics {✒️}

int/news-room/fact-sheets/detail/blood-safety eu/sites/default/files/medias/fichiers/good_practice_guidelines_dec_2013 buffy-coat-derived platelet concentrates circulatory-cell-mediated nanotherapeutic approaches plt-derived extracellular vesicles mouse anti-human cd41a-apc cancer cell-derived tf-evs plt-derived extracellular vesicle tissue factor–bearing microparticles tissue factor-rich microvesicles frac{\mathrm{amount}\ \mathrm{ tumor-shed vesicles depends van wordragen-vlaswinkel rj long-sheng lu drug-loaded plt-based therapy cell-mediated drug delivery plt-extracellular vesicles drug-resistant tumor growth chun austin changou article download pdf tumour cell-derived tf undergo long-term storage plt-cancer interaction loop grant number 104–2314-b-038-040-my3 mda-mb-231 cancer cells anticancer platelet-mimicking nanovehicles slow-release drug delivery optimizing circulation half-lives dual-layer surface coating anti-peg igm elicited plt-cancer intimate connection plt extracellular vesicle ev involving tf-ev delivering anti-cancer agents hydrophilic anti-cancer agents drug delivery strategies platelet membrane-functionalized particles adp-stimulated human platelets dmso-cryopreserved platelet concentrates horseradish peroxidase-conjugated antibodies mda-mb-231 cells/ml therapeutic-grade plt concentrate }\ \mathrm{plt}\ \mathrm{ ev expressing tf tissue factor-independent cryopreserved dox-loaded plt prepare dox-loaded plt mda-mb-231 cells incubated }\ \mathrm{dox}\ \mathrm{ tf-ev convert prothrombin

Payment Methods {📊}

  • Braintree

Questions {❓}

  • PAS or plasma for storage of platelets?
  • To exploit the tumor microenvironment: since the EPR effect fails in the clinic, what is the future of nanomedicine?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Clinical-grade cryopreserved doxorubicin-loaded platelets: role of cancer cells and platelet extracellular vesicles activation loop
         description:Human platelets (PLT) and PLT-extracellular vesicles (PEV) released upon thrombin activation express receptors that interact with tumour cells and, thus, can serve as a delivery platform of anti-cancer agents. Drug-loaded nanoparticles coated with PLT membranes were demonstrated to have improved targeting efficiency to tumours, but remain impractical for clinical translation. PLT and PEV targeted drug delivery vehicles should facilitate clinical developments if clinical-grade procedures can be developed. PLT from therapeutic-grade PLT concentrate (PC; N > 50) were loaded with doxorubicin (DOX) and stored at − 80 °C (DOX-loaded PLT) with 6% dimethyl sulfoxide (cryopreserved DOX-loaded PLT). Surface markers and function of cryopreserved DOX-loaded PLT was confirmed by Western blot and thromboelastography, respectively. The morphology of fresh and cryopreserved naïve and DOX-loaded PLT was observed by scanning electron microscopy. The content of tissue factor-expressing cancer-derived extracellular vesicles (TF-EV) present in conditioned medium (CM) of breast cancer cells cultures was measured. The drug release by fresh and cryopreserved DOX-loaded PLT triggered by various pH and CM was determined by high performance liquid chromatography. The thrombin activated PEV was analyzed by nanoparticle tracking analysis. The cellular uptake of DOX from PLT was observed by deconvolution microscopy. The cytotoxicities of DOX-loaded PLT, cryopreserved DOX-loaded PLT, DOX and liposomal DOX on breast, lung and colon cancer cells were analyzed by CCK-8 assay. 15~36 × 106 molecules of DOX could be loaded in each PLT within 3 to 9 days after collection. The characterization and bioreactivity of cryopreserved DOX-loaded PLT were preserved, as evidenced by (a) microscopic observations, (b) preservation of important PLT membrane markers CD41, CD61, protease activated receptor-1, (c) functional activity, (d) reactivity to TF-EV, and (e) efficient generation of PEV upon thrombin activation. The transfer of DOX from cryopreserved PLT to cancer cells was achieved within 90 min, and stimulated by TF-EV and low pH. The cryopreserved DOX-loaded PLT formulation was 7~23-times more toxic to three cancer cells than liposomal DOX. Cryopreserved DOX-loaded PLT can be prepared under clinically compliant conditions preserving the membrane functionality for anti-cancer therapy. These findings open perspectives for translational applications of PLT-based drug delivery systems.
         datePublished:2020-03-23T00:00:00Z
         dateModified:2020-03-23T00:00:00Z
         pageStart:1
         pageEnd:16
         license:http://creativecommons.org/publicdomain/zero/1.0/
         sameAs:https://doi.org/10.1186/s12929-020-00633-2
         keywords:
            Cryopreserved platelet
            Tissue factor
            Cancer
            Doxorubicin
            Platelet extracellular vesicles
            Drug delivery
            Biomedicine
            general
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12929-020-00633-2/MediaObjects/12929_2020_633_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12929-020-00633-2/MediaObjects/12929_2020_633_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12929-020-00633-2/MediaObjects/12929_2020_633_Fig3_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12929-020-00633-2/MediaObjects/12929_2020_633_Fig4_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12929-020-00633-2/MediaObjects/12929_2020_633_Fig5_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12929-020-00633-2/MediaObjects/12929_2020_633_Fig6_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12929-020-00633-2/MediaObjects/12929_2020_633_Fig7_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12929-020-00633-2/MediaObjects/12929_2020_633_Fig8_HTML.png
         isPartOf:
            name:Journal of Biomedical Science
            issn:
               1423-0127
            volumeNumber:27
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Yu-Wen Wu
               url:https://orcid.org/0000-0001-7636-0393
               affiliation:
                     name:Taipei Medical University
                     address:
                        name:Graduate Institute of Biomedical Materials and Tissue Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei, Taiwan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Cheng-Chain Huang
               affiliation:
                     name:Taipei Medical University
                     address:
                        name:Graduate Institute of Translational Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Chun Austin Changou
               affiliation:
                     name:Taipei Medical University
                     address:
                        name:Graduate Institute of Translational Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
                        type:PostalAddress
                     type:Organization
                     name:Taipei Medical University
                     address:
                        name:The Ph.D. Program for Cancer Biology and Drug Discovery, Center for Translational Medicine, Taipei Medical University, Taipei, Taiwan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Long-Sheng Lu
               url:https://orcid.org/0000-0002-4247-1981
               affiliation:
                     name:Taipei Medical University
                     address:
                        name:Graduate Institute of Biomedical Materials and Tissue Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei, Taiwan
                        type:PostalAddress
                     type:Organization
                     name:Taipei Medical University
                     address:
                        name:International PhD Program in Biomedical Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei, Taiwan
                        type:PostalAddress
                     type:Organization
                     name:Taipei Medical University Hospital
                     address:
                        name:Department of Radiation Oncology, Taipei Medical University Hospital, Taipei, Taiwan
                        type:PostalAddress
                     type:Organization
                     name:Taipei Medical University Hospital
                     address:
                        name:Translational Laboratory, Department of Medical Research, Taipei Medical University Hospital, Taipei, Taiwan
                        type:PostalAddress
                     type:Organization
                     name:Taipei Medical University
                     address:
                        name:International PhD Program in Cell Therapy and Regeneration Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Hadi Goubran
               affiliation:
                     name:University of Saskatchewan
                     address:
                        name:Saskatoon Cancer Centre and College of Medicine, University of Saskatchewan, Saskatchewan, Canada
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Thierry Burnouf
               url:https://orcid.org/0000-0002-0507-9243
               affiliation:
                     name:Taipei Medical University
                     address:
                        name:Graduate Institute of Biomedical Materials and Tissue Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei, Taiwan
                        type:PostalAddress
                     type:Organization
                     name:Taipei Medical University
                     address:
                        name:International PhD Program in Biomedical Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei, Taiwan
                        type:PostalAddress
                     type:Organization
                     name:Taipei Medical University
                     address:
                        name:International PhD Program in Cell Therapy and Regeneration Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Clinical-grade cryopreserved doxorubicin-loaded platelets: role of cancer cells and platelet extracellular vesicles activation loop
      description:Human platelets (PLT) and PLT-extracellular vesicles (PEV) released upon thrombin activation express receptors that interact with tumour cells and, thus, can serve as a delivery platform of anti-cancer agents. Drug-loaded nanoparticles coated with PLT membranes were demonstrated to have improved targeting efficiency to tumours, but remain impractical for clinical translation. PLT and PEV targeted drug delivery vehicles should facilitate clinical developments if clinical-grade procedures can be developed. PLT from therapeutic-grade PLT concentrate (PC; N > 50) were loaded with doxorubicin (DOX) and stored at − 80 °C (DOX-loaded PLT) with 6% dimethyl sulfoxide (cryopreserved DOX-loaded PLT). Surface markers and function of cryopreserved DOX-loaded PLT was confirmed by Western blot and thromboelastography, respectively. The morphology of fresh and cryopreserved naïve and DOX-loaded PLT was observed by scanning electron microscopy. The content of tissue factor-expressing cancer-derived extracellular vesicles (TF-EV) present in conditioned medium (CM) of breast cancer cells cultures was measured. The drug release by fresh and cryopreserved DOX-loaded PLT triggered by various pH and CM was determined by high performance liquid chromatography. The thrombin activated PEV was analyzed by nanoparticle tracking analysis. The cellular uptake of DOX from PLT was observed by deconvolution microscopy. The cytotoxicities of DOX-loaded PLT, cryopreserved DOX-loaded PLT, DOX and liposomal DOX on breast, lung and colon cancer cells were analyzed by CCK-8 assay. 15~36 × 106 molecules of DOX could be loaded in each PLT within 3 to 9 days after collection. The characterization and bioreactivity of cryopreserved DOX-loaded PLT were preserved, as evidenced by (a) microscopic observations, (b) preservation of important PLT membrane markers CD41, CD61, protease activated receptor-1, (c) functional activity, (d) reactivity to TF-EV, and (e) efficient generation of PEV upon thrombin activation. The transfer of DOX from cryopreserved PLT to cancer cells was achieved within 90 min, and stimulated by TF-EV and low pH. The cryopreserved DOX-loaded PLT formulation was 7~23-times more toxic to three cancer cells than liposomal DOX. Cryopreserved DOX-loaded PLT can be prepared under clinically compliant conditions preserving the membrane functionality for anti-cancer therapy. These findings open perspectives for translational applications of PLT-based drug delivery systems.
      datePublished:2020-03-23T00:00:00Z
      dateModified:2020-03-23T00:00:00Z
      pageStart:1
      pageEnd:16
      license:http://creativecommons.org/publicdomain/zero/1.0/
      sameAs:https://doi.org/10.1186/s12929-020-00633-2
      keywords:
         Cryopreserved platelet
         Tissue factor
         Cancer
         Doxorubicin
         Platelet extracellular vesicles
         Drug delivery
         Biomedicine
         general
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12929-020-00633-2/MediaObjects/12929_2020_633_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12929-020-00633-2/MediaObjects/12929_2020_633_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12929-020-00633-2/MediaObjects/12929_2020_633_Fig3_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12929-020-00633-2/MediaObjects/12929_2020_633_Fig4_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12929-020-00633-2/MediaObjects/12929_2020_633_Fig5_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12929-020-00633-2/MediaObjects/12929_2020_633_Fig6_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12929-020-00633-2/MediaObjects/12929_2020_633_Fig7_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs12929-020-00633-2/MediaObjects/12929_2020_633_Fig8_HTML.png
      isPartOf:
         name:Journal of Biomedical Science
         issn:
            1423-0127
         volumeNumber:27
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Yu-Wen Wu
            url:https://orcid.org/0000-0001-7636-0393
            affiliation:
                  name:Taipei Medical University
                  address:
                     name:Graduate Institute of Biomedical Materials and Tissue Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei, Taiwan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Cheng-Chain Huang
            affiliation:
                  name:Taipei Medical University
                  address:
                     name:Graduate Institute of Translational Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Chun Austin Changou
            affiliation:
                  name:Taipei Medical University
                  address:
                     name:Graduate Institute of Translational Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
                     type:PostalAddress
                  type:Organization
                  name:Taipei Medical University
                  address:
                     name:The Ph.D. Program for Cancer Biology and Drug Discovery, Center for Translational Medicine, Taipei Medical University, Taipei, Taiwan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Long-Sheng Lu
            url:https://orcid.org/0000-0002-4247-1981
            affiliation:
                  name:Taipei Medical University
                  address:
                     name:Graduate Institute of Biomedical Materials and Tissue Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei, Taiwan
                     type:PostalAddress
                  type:Organization
                  name:Taipei Medical University
                  address:
                     name:International PhD Program in Biomedical Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei, Taiwan
                     type:PostalAddress
                  type:Organization
                  name:Taipei Medical University Hospital
                  address:
                     name:Department of Radiation Oncology, Taipei Medical University Hospital, Taipei, Taiwan
                     type:PostalAddress
                  type:Organization
                  name:Taipei Medical University Hospital
                  address:
                     name:Translational Laboratory, Department of Medical Research, Taipei Medical University Hospital, Taipei, Taiwan
                     type:PostalAddress
                  type:Organization
                  name:Taipei Medical University
                  address:
                     name:International PhD Program in Cell Therapy and Regeneration Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Hadi Goubran
            affiliation:
                  name:University of Saskatchewan
                  address:
                     name:Saskatoon Cancer Centre and College of Medicine, University of Saskatchewan, Saskatchewan, Canada
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Thierry Burnouf
            url:https://orcid.org/0000-0002-0507-9243
            affiliation:
                  name:Taipei Medical University
                  address:
                     name:Graduate Institute of Biomedical Materials and Tissue Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei, Taiwan
                     type:PostalAddress
                  type:Organization
                  name:Taipei Medical University
                  address:
                     name:International PhD Program in Biomedical Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei, Taiwan
                     type:PostalAddress
                  type:Organization
                  name:Taipei Medical University
                  address:
                     name:International PhD Program in Cell Therapy and Regeneration Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Journal of Biomedical Science
      issn:
         1423-0127
      volumeNumber:27
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Taipei Medical University
      address:
         name:Graduate Institute of Biomedical Materials and Tissue Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei, Taiwan
         type:PostalAddress
      name:Taipei Medical University
      address:
         name:Graduate Institute of Translational Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
         type:PostalAddress
      name:Taipei Medical University
      address:
         name:Graduate Institute of Translational Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
         type:PostalAddress
      name:Taipei Medical University
      address:
         name:The Ph.D. Program for Cancer Biology and Drug Discovery, Center for Translational Medicine, Taipei Medical University, Taipei, Taiwan
         type:PostalAddress
      name:Taipei Medical University
      address:
         name:Graduate Institute of Biomedical Materials and Tissue Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei, Taiwan
         type:PostalAddress
      name:Taipei Medical University
      address:
         name:International PhD Program in Biomedical Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei, Taiwan
         type:PostalAddress
      name:Taipei Medical University Hospital
      address:
         name:Department of Radiation Oncology, Taipei Medical University Hospital, Taipei, Taiwan
         type:PostalAddress
      name:Taipei Medical University Hospital
      address:
         name:Translational Laboratory, Department of Medical Research, Taipei Medical University Hospital, Taipei, Taiwan
         type:PostalAddress
      name:Taipei Medical University
      address:
         name:International PhD Program in Cell Therapy and Regeneration Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
         type:PostalAddress
      name:University of Saskatchewan
      address:
         name:Saskatoon Cancer Centre and College of Medicine, University of Saskatchewan, Saskatchewan, Canada
         type:PostalAddress
      name:Taipei Medical University
      address:
         name:Graduate Institute of Biomedical Materials and Tissue Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei, Taiwan
         type:PostalAddress
      name:Taipei Medical University
      address:
         name:International PhD Program in Biomedical Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei, Taiwan
         type:PostalAddress
      name:Taipei Medical University
      address:
         name:International PhD Program in Cell Therapy and Regeneration Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Yu-Wen Wu
      url:https://orcid.org/0000-0001-7636-0393
      affiliation:
            name:Taipei Medical University
            address:
               name:Graduate Institute of Biomedical Materials and Tissue Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei, Taiwan
               type:PostalAddress
            type:Organization
      name:Cheng-Chain Huang
      affiliation:
            name:Taipei Medical University
            address:
               name:Graduate Institute of Translational Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
               type:PostalAddress
            type:Organization
      name:Chun Austin Changou
      affiliation:
            name:Taipei Medical University
            address:
               name:Graduate Institute of Translational Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
               type:PostalAddress
            type:Organization
            name:Taipei Medical University
            address:
               name:The Ph.D. Program for Cancer Biology and Drug Discovery, Center for Translational Medicine, Taipei Medical University, Taipei, Taiwan
               type:PostalAddress
            type:Organization
      name:Long-Sheng Lu
      url:https://orcid.org/0000-0002-4247-1981
      affiliation:
            name:Taipei Medical University
            address:
               name:Graduate Institute of Biomedical Materials and Tissue Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei, Taiwan
               type:PostalAddress
            type:Organization
            name:Taipei Medical University
            address:
               name:International PhD Program in Biomedical Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei, Taiwan
               type:PostalAddress
            type:Organization
            name:Taipei Medical University Hospital
            address:
               name:Department of Radiation Oncology, Taipei Medical University Hospital, Taipei, Taiwan
               type:PostalAddress
            type:Organization
            name:Taipei Medical University Hospital
            address:
               name:Translational Laboratory, Department of Medical Research, Taipei Medical University Hospital, Taipei, Taiwan
               type:PostalAddress
            type:Organization
            name:Taipei Medical University
            address:
               name:International PhD Program in Cell Therapy and Regeneration Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
               type:PostalAddress
            type:Organization
      name:Hadi Goubran
      affiliation:
            name:University of Saskatchewan
            address:
               name:Saskatoon Cancer Centre and College of Medicine, University of Saskatchewan, Saskatchewan, Canada
               type:PostalAddress
            type:Organization
      name:Thierry Burnouf
      url:https://orcid.org/0000-0002-0507-9243
      affiliation:
            name:Taipei Medical University
            address:
               name:Graduate Institute of Biomedical Materials and Tissue Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei, Taiwan
               type:PostalAddress
            type:Organization
            name:Taipei Medical University
            address:
               name:International PhD Program in Biomedical Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei, Taiwan
               type:PostalAddress
            type:Organization
            name:Taipei Medical University
            address:
               name:International PhD Program in Cell Therapy and Regeneration Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Graduate Institute of Biomedical Materials and Tissue Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei, Taiwan
      name:Graduate Institute of Translational Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
      name:Graduate Institute of Translational Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
      name:The Ph.D. Program for Cancer Biology and Drug Discovery, Center for Translational Medicine, Taipei Medical University, Taipei, Taiwan
      name:Graduate Institute of Biomedical Materials and Tissue Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei, Taiwan
      name:International PhD Program in Biomedical Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei, Taiwan
      name:Department of Radiation Oncology, Taipei Medical University Hospital, Taipei, Taiwan
      name:Translational Laboratory, Department of Medical Research, Taipei Medical University Hospital, Taipei, Taiwan
      name:International PhD Program in Cell Therapy and Regeneration Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan
      name:Saskatoon Cancer Centre and College of Medicine, University of Saskatchewan, Saskatchewan, Canada
      name:Graduate Institute of Biomedical Materials and Tissue Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei, Taiwan
      name:International PhD Program in Biomedical Engineering, College of Biomedical Engineering, Taipei Medical University, Taipei, Taiwan
      name:International PhD Program in Cell Therapy and Regeneration Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan

External Links {🔗}(319)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Particles.js
  • Prism.js

CDN Services {📦}

  • Crossref

5.15s.